Job Openings CEO & Co-Founder Biotech (The Collider Programme)

About the job CEO & Co-Founder Biotech (The Collider Programme)

The Collider Deep-Tech Venture Building Programme Therapeutics & Biotech

Job Description

Are you an entrepreneurial leader in biotech or therapeutics looking to build a spin-off from breakthrough research?

The Collider MWCapital is scouting founders with strategic vision and experience in drug development, biologics or advanced therapies.
You will participate in a 3-month business validation phase with top research teams, and if validated, become the CEO & Co-Founder of a new biotech company.

About the Therapeutics & Biotech Opportunity

Our pipeline includes technologies such as:

  • Novel small molecules with first-in-class mechanisms

  • Light-regulated drugs or targeted delivery approaches

  • Recombinant proteins and biologics for chronic or age-related diseases

  • Rare disease therapeutics (Orphan Drug path)

  • Womens health innovations (fertility, reproductive health)

  • Ophthalmology and neurodegeneration treatments

These projects require founders familiar with preclinical development, regulatory strategy (EMA/FDA), pharma partnerships and fundraising.

Your Challenges as Entrepreneur

  • Defining strategy, IP positioning and development roadmap

  • Structuring preclinical and regulatory pathways (IND-enabling studies)

  • Building partnerships with CROs, pharma, clinicians and KOLs

  • Planning and executing a compelling fundraising strategy

  • Leading operations, team building and early company creation

The Offer

  • Significant equity as CEO & Co-Founder

  • 6,000 stipend during the validation phase (2,000 p/month)

  • Access to a participative loan up to 50K

  • Mentorship from biotech market experts, IP and regulatory 

  • International exposure (4YFN, MWC, DeepTech Alliance)

  • Coworking at Tech Barcelona Pier 01

This Opportunity Is for You If:

  • You are a founder or early-stage biotech leader (therapeutics, biologics, drug discovery)
  • Experienced in preclinical development, regulatory strategy or biotech partnerships
  • Strong in fundraising and strategic decision-making

  • Resilient and comfortable with long development cycles

  • Eligible to work in Spain; fluent in English

Process Timeline

  1. Application Screening - December 2025
  2. Interview Process - January / February 2026
  3. Matchmaking - March 2026

Learn more about The Collider here